Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuraminidase | 5 | 2021 | 36 | 1.700 |
Why?
|
| Mesangial Cells | 3 | 2021 | 37 | 1.510 |
Why?
|
| Lupus Nephritis | 4 | 2021 | 193 | 1.510 |
Why?
|
| Interleukin-6 | 7 | 2017 | 330 | 1.230 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2021 | 175 | 1.080 |
Why?
|
| Kidney | 4 | 2021 | 945 | 0.970 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2021 | 114 | 0.970 |
Why?
|
| Matrix Metalloproteinase 1 | 6 | 2011 | 74 | 0.910 |
Why?
|
| Glycosphingolipids | 2 | 2020 | 51 | 0.690 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2016 | 76 | 0.640 |
Why?
|
| Receptors, CXCR3 | 1 | 2015 | 16 | 0.530 |
Why?
|
| Lipopolysaccharides | 7 | 2021 | 455 | 0.520 |
Why?
|
| Nephritis | 1 | 2015 | 37 | 0.520 |
Why?
|
| Glucose | 4 | 2010 | 307 | 0.510 |
Why?
|
| Mice, Inbred MRL lpr | 4 | 2021 | 118 | 0.510 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 118 | 0.500 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2015 | 126 | 0.500 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2015 | 106 | 0.490 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 756 | 0.480 |
Why?
|
| Myocytes, Cardiac | 1 | 2016 | 442 | 0.410 |
Why?
|
| Fibroblasts | 4 | 2015 | 902 | 0.400 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 597 | 0.400 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2010 | 282 | 0.390 |
Why?
|
| Macrophages | 3 | 2009 | 647 | 0.380 |
Why?
|
| Simvastatin | 2 | 2010 | 34 | 0.340 |
Why?
|
| Sweetening Agents | 1 | 2009 | 23 | 0.330 |
Why?
|
| Ceramides | 5 | 2020 | 578 | 0.310 |
Why?
|
| Enzyme Activation | 2 | 2015 | 791 | 0.310 |
Why?
|
| Cytokines | 2 | 2021 | 866 | 0.280 |
Why?
|
| Cells, Cultured | 5 | 2021 | 2673 | 0.270 |
Why?
|
| Up-Regulation | 5 | 2017 | 682 | 0.260 |
Why?
|
| Animals | 11 | 2021 | 20881 | 0.250 |
Why?
|
| Cell Nucleus | 2 | 2015 | 305 | 0.240 |
Why?
|
| Mice | 9 | 2021 | 8474 | 0.240 |
Why?
|
| Signal Transduction | 6 | 2021 | 2689 | 0.230 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (NADP+)(Phosphorylating) | 1 | 2003 | 4 | 0.230 |
Why?
|
| U937 Cells | 5 | 2012 | 61 | 0.230 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 1293 | 0.220 |
Why?
|
| Cell Proliferation | 4 | 2017 | 1174 | 0.200 |
Why?
|
| Mitochondrial Dynamics | 1 | 2021 | 17 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 2791 | 0.200 |
Why?
|
| Serum | 1 | 2021 | 24 | 0.190 |
Why?
|
| Adipocytes | 2 | 2011 | 88 | 0.180 |
Why?
|
| Organ Transplantation | 1 | 2021 | 110 | 0.180 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 186 | 0.180 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2011 | 124 | 0.180 |
Why?
|
| Lactosylceramides | 2 | 2020 | 27 | 0.170 |
Why?
|
| Graft vs Host Disease | 1 | 2021 | 163 | 0.170 |
Why?
|
| Heart Transplantation | 1 | 2021 | 328 | 0.160 |
Why?
|
| NF-kappa B | 2 | 2012 | 432 | 0.160 |
Why?
|
| Cell Movement | 3 | 2015 | 630 | 0.150 |
Why?
|
| Glycoside Hydrolase Inhibitors | 1 | 2017 | 7 | 0.150 |
Why?
|
| Myocardium | 2 | 2015 | 1204 | 0.150 |
Why?
|
| Pressure | 2 | 2015 | 252 | 0.150 |
Why?
|
| Cell Line | 3 | 2017 | 1752 | 0.150 |
Why?
|
| Receptors, IgG | 1 | 2017 | 94 | 0.140 |
Why?
|
| Aorta | 2 | 2015 | 316 | 0.140 |
Why?
|
| Angiotensins | 1 | 2016 | 16 | 0.130 |
Why?
|
| Phenylephrine | 1 | 2016 | 61 | 0.130 |
Why?
|
| Chemokine CXCL9 | 1 | 2015 | 8 | 0.130 |
Why?
|
| Chemokine CXCL10 | 1 | 2015 | 21 | 0.130 |
Why?
|
| Dasatinib | 1 | 2015 | 17 | 0.130 |
Why?
|
| Cats | 1 | 2016 | 292 | 0.130 |
Why?
|
| Telomerase | 3 | 2005 | 85 | 0.130 |
Why?
|
| Coculture Techniques | 3 | 2011 | 147 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 3 | 2006 | 561 | 0.130 |
Why?
|
| Humans | 17 | 2021 | 68618 | 0.130 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 481 | 0.130 |
Why?
|
| Antigens, CD | 1 | 2015 | 230 | 0.120 |
Why?
|
| Periodontium | 1 | 2014 | 11 | 0.120 |
Why?
|
| Chronic Periodontitis | 1 | 2014 | 18 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2550 | 0.120 |
Why?
|
| Mice, Knockout | 2 | 2015 | 1692 | 0.120 |
Why?
|
| Monocytes | 2 | 2012 | 210 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 126 | 0.110 |
Why?
|
| Female | 7 | 2021 | 38074 | 0.110 |
Why?
|
| Extracellular Matrix | 2 | 2015 | 493 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2005 | 312 | 0.110 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2010 | 140 | 0.110 |
Why?
|
| Integrin beta3 | 1 | 2012 | 35 | 0.100 |
Why?
|
| Cell Communication | 2 | 2009 | 116 | 0.100 |
Why?
|
| Paracrine Communication | 1 | 2011 | 31 | 0.100 |
Why?
|
| Drug Synergism | 2 | 2009 | 260 | 0.100 |
Why?
|
| Heart | 1 | 2015 | 850 | 0.090 |
Why?
|
| Male | 5 | 2021 | 37321 | 0.090 |
Why?
|
| Phagocytes | 1 | 2010 | 15 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2008 | 492 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2010 | 71 | 0.090 |
Why?
|
| Osteopontin | 1 | 2009 | 28 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2005 | 629 | 0.080 |
Why?
|
| Lymphocyte Antigen 96 | 1 | 2009 | 10 | 0.080 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2009 | 15 | 0.080 |
Why?
|
| STAT1 Transcription Factor | 1 | 2008 | 35 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2009 | 86 | 0.080 |
Why?
|
| Pyridinium Compounds | 2 | 2006 | 40 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 710 | 0.080 |
Why?
|
| Periodontal Diseases | 1 | 2008 | 54 | 0.080 |
Why?
|
| Interferon-gamma | 1 | 2008 | 241 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2012 | 954 | 0.070 |
Why?
|
| Cell Division | 2 | 2005 | 541 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2008 | 249 | 0.070 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2006 | 8 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 307 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 2 | 2021 | 247 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2006 | 1851 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 532 | 0.060 |
Why?
|
| Focal Adhesion Kinase 2 | 2 | 2015 | 18 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2008 | 753 | 0.060 |
Why?
|
| Silver Staining | 1 | 2003 | 11 | 0.060 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2003 | 50 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2003 | 88 | 0.060 |
Why?
|
| Telomere | 1 | 2003 | 59 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2003 | 144 | 0.060 |
Why?
|
| Chromatin | 1 | 2003 | 76 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 123 | 0.060 |
Why?
|
| Gingiva | 2 | 2014 | 34 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2003 | 155 | 0.060 |
Why?
|
| Ultraviolet Rays | 1 | 2003 | 130 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2003 | 246 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 1745 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 261 | 0.050 |
Why?
|
| Plasmids | 1 | 2003 | 258 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 468 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2003 | 489 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2003 | 434 | 0.050 |
Why?
|
| Transfection | 1 | 2003 | 782 | 0.050 |
Why?
|
| Glycolysis | 1 | 2021 | 79 | 0.050 |
Why?
|
| Proteins | 1 | 2004 | 474 | 0.050 |
Why?
|
| Protein Binding | 1 | 2003 | 1027 | 0.050 |
Why?
|
| Peptides | 1 | 2003 | 455 | 0.050 |
Why?
|
| Phosphorous Acids | 1 | 2020 | 4 | 0.040 |
Why?
|
| Oseltamivir | 1 | 2020 | 6 | 0.040 |
Why?
|
| G(M3) Ganglioside | 1 | 2020 | 7 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2004 | 617 | 0.040 |
Why?
|
| Proteinuria | 1 | 2020 | 136 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 266 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2021 | 384 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2021 | 458 | 0.040 |
Why?
|
| Interleukin-1beta | 2 | 2008 | 88 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 507 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 1070 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 1342 | 0.030 |
Why?
|
| Constriction | 1 | 2015 | 37 | 0.030 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2015 | 20 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 55 | 0.030 |
Why?
|
| Time Factors | 1 | 2003 | 4655 | 0.030 |
Why?
|
| Crown Lengthening | 1 | 2014 | 3 | 0.030 |
Why?
|
| Gingivoplasty | 1 | 2014 | 7 | 0.030 |
Why?
|
| Periodontal Attachment Loss | 1 | 2014 | 12 | 0.030 |
Why?
|
| Periodontal Pocket | 1 | 2014 | 15 | 0.030 |
Why?
|
| Tooth Extraction | 1 | 2014 | 27 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2012 | 1664 | 0.030 |
Why?
|
| Fibrosis | 1 | 2015 | 371 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 209 | 0.030 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2012 | 15 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 25 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2012 | 89 | 0.030 |
Why?
|
| S100 Proteins | 1 | 2012 | 42 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2015 | 481 | 0.030 |
Why?
|
| Fibronectins | 1 | 2012 | 130 | 0.030 |
Why?
|
| Receptor Cross-Talk | 1 | 2011 | 16 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 236 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 324 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 2012 | 213 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 250 | 0.020 |
Why?
|
| Curcumin | 1 | 2010 | 23 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1593 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 60 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 61 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1174 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 150 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2010 | 85 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 147 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 134 | 0.020 |
Why?
|
| Collagen | 1 | 2012 | 636 | 0.020 |
Why?
|
| Flavonoids | 1 | 2009 | 109 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 331 | 0.020 |
Why?
|
| Imidazoles | 1 | 2009 | 175 | 0.020 |
Why?
|
| Antibodies | 1 | 2009 | 241 | 0.020 |
Why?
|
| RNA Interference | 1 | 2009 | 266 | 0.020 |
Why?
|
| Gingival Crevicular Fluid | 1 | 2008 | 9 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2008 | 20 | 0.020 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2008 | 22 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2008 | 59 | 0.020 |
Why?
|
| Pyridines | 1 | 2009 | 261 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 742 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 306 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 160 | 0.020 |
Why?
|
| RNA | 1 | 2008 | 171 | 0.020 |
Why?
|
| Gene Expression | 1 | 2009 | 770 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 562 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2008 | 203 | 0.020 |
Why?
|
| Antioxidants | 1 | 2009 | 304 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2008 | 158 | 0.020 |
Why?
|
| Inactivation, Metabolic | 1 | 2006 | 28 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2006 | 41 | 0.020 |
Why?
|
| Cations | 1 | 2006 | 51 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2008 | 204 | 0.020 |
Why?
|
| Aged | 2 | 2014 | 14862 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2006 | 83 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2006 | 282 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 626 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2006 | 238 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2006 | 304 | 0.020 |
Why?
|
| Trypan Blue | 1 | 2004 | 24 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2004 | 36 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2004 | 66 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 1553 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2004 | 120 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 200 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 251 | 0.010 |
Why?
|
| Obesity | 1 | 2011 | 1076 | 0.010 |
Why?
|
| Thiazoles | 1 | 2004 | 95 | 0.010 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2004 | 62 | 0.010 |
Why?
|
| Middle Aged | 2 | 2014 | 21147 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 284 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 21403 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 852 | 0.010 |
Why?
|
| Mitochondria | 1 | 2004 | 643 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 4848 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 1641 | 0.010 |
Why?
|
| Young Adult | 1 | 2008 | 5717 | 0.010 |
Why?
|